Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

161 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase I/II trial of interleukin-15--stimulated natural killer cell infusion after haplo-identical stem cell transplantation for pediatric refractory solid tumors.
Pérez-Martínez A, Fernández L, Valentín J, Martínez-Romera I, Corral MD, Ramírez M, Abad L, Santamaría S, González-Vicent M, Sirvent S, Sevilla J, Vicario JL, de Prada I, Diaz MÁ. Pérez-Martínez A, et al. Among authors: abad l. Cytotherapy. 2015 Nov;17(11):1594-603. doi: 10.1016/j.jcyt.2015.07.011. Epub 2015 Sep 1. Cytotherapy. 2015. PMID: 26341478 Clinical Trial.
Prognostic factors and outcomes for pediatric patients receiving an haploidentical relative allogeneic transplant using CD3/CD19-depleted grafts.
Diaz MA, Pérez-Martínez A, Herrero B, Deltoro N, Martinez I, Ramirez M, Abad L, Sevilla J, Merino E, Ruiz J, Vicario JL, Gonzalez-Vicent M. Diaz MA, et al. Among authors: abad l. Bone Marrow Transplant. 2016 Sep;51(9):1211-6. doi: 10.1038/bmt.2016.101. Epub 2016 Apr 18. Bone Marrow Transplant. 2016. PMID: 27088380
Haploidentical Stem Cell Transplantation in Children With Hematological Malignancies Using αβ+ T-Cell Receptor and CD19+ Cell Depleted Grafts: High CD56dim/CD56bright NK Cell Ratio Early Following Transplantation Is Associated With Lower Relapse Incidence and Better Outcome.
Diaz MA, Zubicaray J, Molina B, Abad L, Castillo A, Sebastian E, Galvez E, Ruiz J, Vicario JL, Ramirez M, Sevilla J, González-Vicent M. Diaz MA, et al. Among authors: abad l. Front Immunol. 2019 Oct 30;10:2504. doi: 10.3389/fimmu.2019.02504. eCollection 2019. Front Immunol. 2019. PMID: 31736949 Free PMC article.
T-Cell Depleted Haploidentical Transplantation in Children With Hematological Malignancies: A Comparison Between CD3+/CD19+ and TCRαβ+/CD19+ Depletion Platforms.
Gonzalez-Vicent M, Molina B, Lopez I, Zubicaray J, Ruiz J, Vicario JL, Sebastián E, Iriondo J, Castillo A, Abad L, Ramirez M, Sevilla J, Diaz MA. Gonzalez-Vicent M, et al. Among authors: abad l. Front Oncol. 2022 Jun 20;12:884397. doi: 10.3389/fonc.2022.884397. eCollection 2022. Front Oncol. 2022. PMID: 35795036 Free PMC article.
Optical Genome Mapping as a New Tool to Overcome Conventional Cytogenetics Limitations in Patients with Bone Marrow Failure.
Iriondo J, Gómez A, Zubicaray J, Garcia-Martinez J, Abad L, Matesanz C, Giménez R, Galán A, Sanz A, Sebastián E, González de Pablo J, de la Cruz A, Ramírez M, Sevilla J. Iriondo J, et al. Among authors: abad l. Genes (Basel). 2024 Apr 27;15(5):559. doi: 10.3390/genes15050559. Genes (Basel). 2024. PMID: 38790188 Free PMC article.
Role of the mesenchymal stromal cells in bone marrow failure of Fanconi Anemia patients.
Zubicaray J, Ivanova M, Iriondo J, García Martínez J, Muñoz-Viana R, Abad L, García-García L, González de Pablo J, Gálvez E, Sebastián E, Ramírez M, Madero L, Díaz MÁ, González-Murillo Á, Sevilla J. Zubicaray J, et al. Among authors: abad l. Front Cell Dev Biol. 2024 Jul 25;12:1286815. doi: 10.3389/fcell.2024.1286815. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39119037 Free PMC article.
161 results